iopromide has been researched along with Biliary Tract Cancer in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JY | 1 |
| Kim, SH | 1 |
| Eun, HW | 1 |
| Lee, MW | 1 |
| Lee, JY | 1 |
| Han, JK | 1 |
| Choi, BI | 1 |
1 other study available for iopromide and Biliary Tract Cancer
| Article | Year |
|---|---|
Differentiation between biliary cystic neoplasms and simple cysts of the liver: accuracy of CT.
Topics: Adult; Aged; Biliary Tract Neoplasms; Chi-Square Distribution; Contrast Media; Cystadenocarcinoma; C | 2010 |